Management of Acute Ischemic Stroke with Large Vessel Occlusion in an Extreme Age Patient: Case Report


  • Udom Suthiponpaisan MedPark Hospital
  • Boonthida Hooncharoen


Cerebral infarction, elderly, treatment


Ischemic stroke, the most common type of stroke, is an emergent condition caused by cerebral arterial blood supply disruption as blood clot occlusion. Management for restoration of blood circulation can be medical therapy with thrombolytic agent and/or mechanical thrombectomy. With possible side effects of both methods, most randomized clinical trials often excluded patients age > 80 years old. This has led to limit data on efficacy and safety of ischemic stroke management in very elderly patients. In this article, we report an extreme age patient who received both medical and surgical interventions. Complete resolution of angiographic defects (mTICI 3) and excellent clinical outcome (no neurological deficit at 90 days) were achieved. Data from literature review of case report studies, guideline recommendation for management, selective indications, efficacy, safety and side effects of each treatment are also presented.


Download data is not yet available.


Khandelwal, P., D.R. Yavagal, and R.L. Sacco, Acute Ischemic Stroke Intervention. J Am Coll Cardiol, 2016. 67(22):p.2631-44.

Ramirez, L., et al., Trends in Acute Ischemic Stroke Hospitalizations in the United States. J Am Heart Assoc, 2016. 5(5).

Mortimer, A.M., M.D. Bradley, and S.A. Renowden, Endovascular therapy in hyperacute ischaemic stroke: history and current status. Interv Neuroradiol, 2013. 19(4):p.506-18.

Chen, C.J., et al., Endovascular vs medical management of acute ischemic stroke. Neurology, 2015. 85(22): p. 1980-90.

Parr, E., P. Ferdinand, and C. Roffe, Management of Acute Stroke in the Older Person. Geriatrics (Basel), 2017.2(3).

Goyal, M., et al., Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet, 2016. 387(10029):p.1723-31.

Yamaguchi, T., et al., Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke, 2006. 37(7):p.1810-5.

Dong, Y., et al., Low-dose intravenous tissue plasminogen activator for acute ischaemic stroke: an alternative or a new standard? Stroke Vasc Neurol, 2016. 1(3):p.115-121.

Powers, W.J., et al., Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke, 2019. 50(12):p.e344-e418.

Andrews, C.E., et al., Revascularization and functional outcomes after mechanical thrombectomy for acute ischemic stroke in elderly patients. J Neurosurg, 2019. 132(4):p.1182-1187.

Imahori, T., et al., Mechanical Thrombectomy for Acute Ischemic Stroke Patients Aged 80 Years or Older. J Stroke Cerebrovasc Dis, 2017. 26(12):p.2793-2799.

McDonough, R.V., et al., Functional Outcomes of Patients >/=85 Years With Acute Ischemic Stroke Following EVT: A HERMES Substudy. Stroke, 2022. 53(7):p.2220-2226.

Liaw, N. and D. Liebeskind, Emerging therapies in acute ischemic stroke. F1000Res, 2020. 9.

Comai, A., et al., Sequential endovascular thrombectomy approach (SETA) to acute ischemic stroke: preliminary single-centre results and cost analysis. Radiol Med, 2015. 120(7):p.655-61.

Turk, A.S., 3rd, et al., Aspiration thrombectomy versus stent retriever thrombectomy as first-line approach for large vessel occlusion (COMPASS): a multicentre, randomised, open label, blinded outcome, non-inferiority trial. Lancet, 2019. 393(10175):p.998-1008.




How to Cite

Suthiponpaisan U, Hooncharoen B. Management of Acute Ischemic Stroke with Large Vessel Occlusion in an Extreme Age Patient: Case Report. J Thai Stroke Soc [Internet]. 2023 Aug. 15 [cited 2023 Dec. 8];22(2):34. Available from:



Case Report